Quick Answer
Nuvation Bio Inc. reported Net Income of -$204.63 million for fiscal year 2025.
Nuvation Bio Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$204.63M | +64.0% |
| 2024 | -$567.94M | -649.2% |
| 2023 | -$75.80M | +27.3% |
| 2022 | -$104.20M | -20.0% |
| 2021 | -$86.85M | -108.5% |
| 2020 | -$41.66M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$55.79M | -35.4% | +5.4% |
| June 30, 2025 | -$59.01M | +87.2% | -10.8% |
| March 31, 2025 | -$53.24M | -259.9% | -29.2% |
| September 30, 2024 | -$41.21M | -109.7% | +91.1% |
| June 30, 2024 | -$462.49M | -2140.8% | -3026.6% |
| March 31, 2024 | -$14.79M | +31.9% | +24.7% |
| September 30, 2023 | -$19.65M | +27.8% | +4.8% |
| June 30, 2023 | -$20.64M | +40.8% | +5.0% |
- Nuvation Bio Inc. showed an increase of +64.0% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Nuvation Bio Inc.’s net income has declined by 391.2% (from -$41.66 million to -$204.63 million).
- The most recent figure is from Nuvation Bio Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: